Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-19-062031

Director sold 36,647 shares at an average $17.20 ($630,352)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MARLETT CHRISTOPHER A Director 2019-12-23 Sale −17,000 $16.82 $285,940 803,850 I: show line 1 in the form
MARLETT CHRISTOPHER A Director 2019-12-26 Sale −19,647 $17.53 $344,412 784,203 I: show line 2 in the form
Open-market sales · 36,647 sh · avg $17.20 · $630,352
Loading xslF345X03/doc4.xml…